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Disclaimer 
 
 
Certain commercial equipment, instruments, and materials are identified in 
this report to specify adequately the experimental procedure. In no case does such identification 
imply recommendation or endorsement by the European Commission, nor does it imply that the 
material or equipment is necessarily the best available for the purpose. 
 
 1 
Summary 
 
This report describes the preparation of two milk powder matrix reference materials (ERM-
BB492 and ERM-BB493) and the certification of their content (mass fraction) of 
oxytetracycline. 
 
The preparation and processing of the material, homogeneity and stability studies, and the 
characterisation are described hereafter and the results are discussed. Uncertainties were 
estimated in compliance with ISO Guide 98-3, Guide to the Expression of Uncertainty in 
Measurement (GUM) [1]. 
 
For ERM-BB492, the uncertainty contains contributions from possible heterogeneity, 
instability, characterisation, and purity of the common calibrant. The certified value is listed 
below: 
 
Mass fraction in the 
reconstituted material 
Certified value 1) 
[µg/kg] 
Uncertainty 2) 
[µg/kg] 
Number of accepted 
sets of results 
Sum of oxytetracycline and 4-
epi-oxytetracycline  101 11 10 
1) The value represents the mass fraction based on the unweighted mean of means of accepted results. 
2) Expanded uncertainty (k = 2) of the value defined in 1). 
 
The certified value and its uncertainty is based on a minimum sample intake of 1.00 g 
reconstituted material. 
 
 
For ERM-BB493, the following certified value has been assigned: 
 
Mass fraction in the reconstituted 
material 
Certified value 1) 
[µg/kg] 
Sum of oxytetracycline and 4-epi-
oxytetracycline  < 5 
1) This value corresponds to the limit of quantification (LOQ) of the most sensitive method in the 
characterisation study. The certified value is below 5 µg/kg with a 95% level of confidence. 
 
The indicative value is based on a minimum sample intake of 3.50 g reconstituted material. 
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1 Glossary 
 
ANOVA ...........................Analysis of variances 
b ......................................Slope of regression line 
BCR ................................Community Bureau of Reference 
C18...................................Octadecyl silica 
CAS.................................Chemical Abstracts Services 
cKFT ...............................Coulometric Karl Fischer titration 
CRM................................Certified reference material 
DAD ................................Diode-array detector 
DSC ................................Differential scanning calorimetry 
EDQM .............................European Directorate for the Quality of Medicines 
EOTC..............................4-epi-oxytetracycline 
ERM................................European Reference Material 
ESI ..................................Electrospray ionisation 
GUM................................Guide to the Expression of Uncertainty in Measurement 
i .......................................Position of result in the analytical sequence (homogeneity study) 
IRMM ..............................Institute for Reference Materials and Measurements 
IUPAC.............................International Union for Pure and Applied Chemistry 
LC ...................................Liquid chromatography 
LC-MS/MS.......................Liquid chromatography-tandem mass spectrometry 
LLE..................................Liquid liquid extraction 
MCAC .............................Metal-chelate affinity chromatography 
m/m.................................Mass-to-mass 
MRL ................................Maximum residue limit 
MRM ...............................Multiple reaction monitoring 
MS ..................................Mass spectrometry 
MSbetween-unit......................Mean of squares between units from a 2-way ANOVA 
MSwithin-sample (error) ..............Mean of squares within a unit from a 2-way ANOVA 
n ......................................Number of replicates 
ODS ................................Octadecyl silica 
OTC ................................Oxytetracycline 
PET.................................Polyethylene terephtalate 
PSA.................................Particle size analysis 
QC ..................................Quality control 
qNMR..............................Quantitative nuclear magnetic resonance 
RP...................................Reversed phase 
RSD ................................Relative standard deviation 
RSDstab ............................Relative standard deviation of all results of the stability study 
s ......................................Standard deviation 
sbb....................................Between-bottle standard deviation 
SI ....................................International Systems of Units 
S/N..................................Signal-to-noise ratio 
SPE.................................Solid phase extraction 
swb ...................................Within-bottle standard deviation 
tα,df ...................................Critical t-value for a t-test, with a level of confidence of 1-α, and  
    df degrees of freedom 
TG-FTIR..........................Thermogravimetry coupled to Fourier-transform infrared 
spectrometry 
TOF.................................Time-of-flight 
u*bb ..................................Relative standard uncertainty due to the heterogeneity that can be 
hidden by the method repeatability 
ubb ...................................Relative standard uncertainty due to between-bottle heterogeneity 
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ucal ...................................Relative uncertainty of common calibrant 
uchar .................................Relative uncertainty of the characterisation exercise 
uCRM, rel .............................Combined relative uncertainty of certified value 
UCRM ................................Expanded uncertainty of certified value 
UCRM, rel ............................Expanded, relative uncertainty of certified value 
ults....................................Relative uncertainty of long-term stability 
umeas ................................Uncertainty of measurement result 
usts ...................................Relative uncertainty of short-term stability 
u∆ ....................................Combined uncertainty of certified value and measured value 
U∆....................................Expanded uncertainty of certified value and measured value 
UPLC ..............................Ultra-performance liquid chromatography 
x ......................................Pre-defined shelf life 
xi......................................Time point i in an isochronous stability study 
∆ .....................................Difference between two measurement results 
∆m....................................Difference between measured and certified value 
vKFT ...............................Volumetric Karl Fischer titration 
νMSwithin .............................Degrees of freedom of MSwithin 
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2 Introduction 
2.1 Background 
Oxytetracycline (OTC) is a broad-spectrum antibiotic highly effective against many bacteria. 
It is produced through fermentation by the soil bacterium Streptomyces rimosus [2]. OTC is 
approved for use in a variety of food-producing animals such as poultry, sheep, goat, swine, 
and fish, and widely used in the treatment of lactating and non-lactating dairy cattle for 
treatment of bacterial infections such as enteritis, pneumonia, shipping fever, diphtheria, and 
foot rot [3]. Residues of OTC can therefore be found in meat tissues, but also in inner organs 
(liver, kidney) and animal products such as eggs and milk, especially if the recommended 
dosage and/or the necessary withdrawal period are not respected.  
 
In order to produce and safeguard reliable analytical results which are necessary to ensure 
effective consumer protection, a certified reference material (BCR-492) was made available 
by the Community Bureau of Reference. BCR-492 was certified in the 1990s with an OTC 
target concentration of 300 µg/L milk, based on the Official French screening method at that 
time [4]. Since that time, legal requirements in the European Union have changed, and for 
OTC (defined in European legislation as the sum of oxytetracycline and its 4-epimer), a 
provisional maximum residue limit (MRL) of 100 µg/kg in milk has been stipulated [5], and 
later on, this MRL has been confirmed and fixed at that concentration [6]. 
 
For both screening, but especially confirmation analysis, liquid chromatography - diode array 
detection (LC-DAD) as well as liquid chromatography-tandem mass spectrometry (LC-
MS/MS) methods are used, with a clear trend towards LC-MS/MS methods in recent years. 
An analytical challenge in the analysis of OTC and other tetracyclines is their isomerisation in 
solution. In slightly acidic medium, OTC is prone to a specific type of isomerisation known as 
epimerisation, which occurs at the C-4 atom (Figure 1) and results in the formation of 4-epi-
oxytetracycline, EOTC [7]. The process is reversible and depends on the pH, the 
temperature, and the type of solution in which OTC is dissolved [7,8]. Moreover, 
epimerisation is catalysed by multi-valent cations, urea, citrate, and phosphate [9]. Also, the 
food matrix and its properties substantially influence the degree of epimerisation, with OTC 
epimerisation being reported in meat and inner organs [10], honey [11], and egg yolk [12], 
but not in milk [13]. Most currently used chromatographic methods do not distinguish 
between OTC and 4-epi-OTC (coelution of compounds); however, several papers have been 
published, demonstrating the feasibility of chromatographic separation of TCs and their 4-
epimers [13 -16]. 
2.2 Choice of the material 
Bovine milk was chosen as the material matrix in order to be consistent with BCR-492. In 
contrast to BCR-492 (skimmed milk), a partially skimmed milk (fat content 1.5 m/m %) was 
used as starting material. It was decided to process the milk to a powder by applying spray 
drying, a process which is used in the industry to produce milk powder. Moreover, 
experiments at IRMM revealed that the spray-dried powder could more easily be 
reconstituted than lyophilised milk powder (better and quicker dissolution). 
 
The envisaged target concentration for candidate ERM-BB492 was 100 µg/kg. In addition, a 
blank milk powder (candidate ERM-BB493) was produced. Table 1 and Figure 1 define the 
analytes in ERM-BB492 and ERM-BB493. 
  7 
2.3 Definition of analyte and chemical structure 
Table 1. Definition of the oxytetracycline analytes comprised in ERM-BB492 and ERM-
BB493 
Trivial name and 
abbreviation IUPAC name CAS number 
Chemical 
formula 
Molecular 
mass 
(g/mol) 
Oxytetracycline 
(OTC) 
(2E,4S,4aR,5S,5aR,6S,12aS)-2-
[amino(hydroxy)methylidene]-4-
(dimethylamino)-5,6,10,11,12a-
pentahydroxy-6-methyl-4,4a,5,5a-
tetrahydrotetracene-1,3,12-trione 
79-57-2 C22H24N2O9 460.43 
4-epioxytetracycline 
(4-epi-OTC) 
(2E,4R,6S,12aS)-2-
[amino(hydroxy)methylidene]-4-
(dimethylamino)-5,6,10,11,12a-
pentahydroxy-6-methyl-4,4a,5,5a-
tetrahydrotetracene-1,3,12-trione 
 
14206-58-7 C22H24N2O9 460.43 
 
Fig. 1: Chemical structures of oxytetracycline (left) and 4-epi-oxytetracycline (right) 
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4 Processing of the material 
The processing of partially skimmed bovine milk into a spray-dried powder was carried out at 
the Staatliche Milchwirtschaftliche Lehr- und Versuchsanstalt, Wangen im Allgäu, Germany. 
First, whole milk and skimmed milk were mixed to obtain milk with 1.5 m/m % fat content. 
The milk was thermally preconcentrated in an evaporator by a factor of 2.8; this step was 
necessary to ensure that the subsequent spray-drying yields a powder of suitable properties 
(particle size, residual water content, and reconstitutability).  
 
The blank material was spray-dried.  
 
For the spiked material, a spike solution was prepared by dissolving pure crystalline OTC 
dihydrate (Sigma Aldrich, Bornem, Belgium) in 20 (v/v) % methanol. 2 L of preconcentrated 
milk were then spiked with the OTC solution, and after extensive stirring, the spiked milk was 
added stepwise into 54 L of preconcentrated milk to yield the final product with a target OTC 
content of about 100 µg/kg. The milk was again stirred extensively, and then subjected to 
spray-drying. All spiking and dilution steps were performed on calibrated balances. 
 
The process yield after spray-drying was 12 kg of both blank milk powder and OTC-
containing milk powder. These were packed under inert gas and shipped to IRMM. Both milk 
powders were extensively mixed in a 3-dimensional mixer (Dynamix CM-200 WAB, Basel, 
Switzerland) for 1 hour to ensure homogenisation. Due to the hygroscopic behaviour of the 
material, filling was performed in a glove box under nitrogen atmosphere. A vibrating feeder 
(Fritsch, Idar-Oberstein, Germany) was used to fill 5.5 g portions of powder in 30 mL amber 
glass vials which were then closed with rubber stoppers. The vials were then sealed with 
metal caps, using a Bausch & Ströbel capping machine (Ilshofen, Germany). After labelling, 
sample sets were produced by putting together one vial of ERM-BB492 (spiked material) and 
one vial of ERM-BB493 (blank material) and sealing those in a metalized PET pouch for 
additional protection from light, humidity, and entrainment of air.  
 
In total, 1300 bottles each of ERM-BB492 and 493 were processed; they were stored after 
production at -70 ºC. 
 
5 Material characterisation measurements 
5.1 Water content 
The water content in the final materials was measured by volumetric Karl Fischer titration 
(vKFT) [17]. Ten bottles of the batch were chosen using a random stratified sample picking 
scheme and analysed in duplicate. The determined mean water content and its standard 
deviation was 2.50 ± 0.08 g/100 g for ERM-BB492 and 2.69 ± 0.11 g/100 g for ERM-BB493. 
5.2 Particle size measurements 
Particle size analysis (PSA) was performed using laser diffraction spectrometry. Five bottles 
were chosen from the final material using a random stratified sample-picking scheme and 
analysed over a range of 0.5 to 1750 µm using a Helos laser light scattering instrument 
(Sympatec GmbH System-Partikel-Technik, Clausthal-Zellerfeld, DE). The determined top 
particle size for the milk powder was 360 µm. About 50 % of all particles were smaller than 
30 µm and approximately 10 % of all particles were smaller than 9 µm (same values for both 
materials). 
 
  11 
6 Homogeneity study 
For the homogeneity study, 15 samples of ERM-BB492 were chosen using a random 
stratified sample selection scheme and analysed in triplicate for their OTC content (sum of 
OTC and 4-epi-OTC). Measurements were performed with an in-house validated LC-ESI-
MS/MS method compliant with Commission Decision 2002/657/EC. Matrix-matched 
calibration was performed by spiking neat standard solutions to blank material (lyophilized 
pork powder provided by IRMM). No internal standard was used. One g of milk powder was 
reconstituted with 8.15 g water, and 1 g of the resulting milk was used as the sample intake 
for analysis. 
 
As not all samples could be analysed in one analytical series, they were split over different 
series and run over different days in such a way that, for each bottle, one replicate was 
analysed on each analysis day (n=3). Within a series (day), samples were analysed in a 
random order. Moreover, two consecutive injections were made of each sample replicate, 
and the average was taken as the result for the replicate.  
 
Data were checked for single and double outliers by applying the Grubbs test at a confidence 
level of 95% and 99%; no outlier was detected. Regression analysis was performed to detect 
possible trends regarding the filling sequence or analytical sequence. In the filling sequence, 
the slope was indistinguishable from zero at both 95 and 99% level, whereas in the analytical 
sequence a significant slope (test value 2.43, critical value 2.02) was observed at the 95% 
level for the analytical sequence (no significant slope at 99% level). 
A t-test (data not shown) revealed a significant difference of day means, which made it 
necessary to analyse the data by 2-way ANOVA, thereby differentiating between sample-to-
sample, day-to-day, and random effects. 
In conclusion, the distribution of OTC in the material can be regarded as sufficiently 
homogeneous. Furthermore it was checked whether the data followed a normal or unimodal 
distribution using normal probability plots and histograms, respectively. Individual data and 
sample averages showed a unimodal distribution. Finally, the uncertainty contribution from 
possible heterogeneity was estimated by a two-way analysis of variance (ANOVA) [18]: 
 
Method repeatability (swb) expressed as a relative standard deviation is given as follows: 
 
y
MS
s
errorsamplewithin
wb
)(−
=  
MSwithin-sample (error): mean square within a bottle from a 2-way ANOVA 
y : average of all results of the homogeneity study 
 
Between-unit variability (sbb) expressed as a relative standard deviation is given by the 
following equation:  
 
y
n
MSMS
s
errorsamplewithinunitbetween
bb
)(−− −
=  
MSbetween-unit: mean square among units from a 2-way ANOVA 
n: number of replicates for a sample 
 
The heterogeneity that can be hidden by method repeatability [19] is defined as follows: 
 
  4
)(
* 2
errorsampleMSwithin
wb
bb
n
s
u
−
ν
=  
νMSwithin-sample (error): degrees of freedom of MSwithin-sample (error) 
  12 
The larger value of sbb or u*bb was used as uncertainty contribution for homogeneity, ubb (see 
Table 2 for a summary of results, values were converted into relative uncertainties). 
 
Table 2. Homogeneity study results for ERM-BB492 
RSD [%] 5.761 
MSwithin (error) 15.17435 
MSbetween sample 57.10739 
MSbetween day 522.33550 
swb [%] 3.125 
sbb [%] 2.999 
u*bb [%] 0.933 
ubb [%] 2.999 
 
 
6.1 Minimum sample intake 
For ERM-BB492, 1 g was the sample intake used in the homogeneity and stability studies. 
Therefore, the minimum sample intake is 1 g of reconstituted material, proving that the 
samples are homogeneous at least at this level. The difference between the amount of 
reconstituted material and the minimum sample intake shall be noted: the laboratory 
performing the analyses reconstituted 1 g of powder with 8.15 g of water, and from the 9.15 g 
of reconstituted milk, an aliquot of 1 g was taken for analysis. 
 
For ERM-BB493 (blank material), no homogeneity and short-term stability study was 
performed. The minimum sample intake is 3.5 g , which was the sample intake of laboratory 
12 in the characterisation study, operating the method with the lowest LOD (see page 22). 
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7 Stability studies 
7.1 Short-term stability study 
 
A four weeks isochronous study [20] was performed to evaluate stability of ERM-BB492 
during transport. Twenty samples were selected from the produced batch using a random 
stratified sample picking scheme.  
 
Samples were stored at +4 °C, +18 °C, +60 °C and at a reference temperature of -70 °C. 
Two bottles were stored at each temperature for 0, 1, 2, and 4 weeks. After the indicated 
storage periods, the samples were transferred to storage at -70 °C until analysis. Samples 
were dispatched to the testing laboratory on dry ice. In total, 20 samples (3 temperatures x 3 
storage times x 2 units/time point = 18 samples, and 2 samples stored at reference 
termperature throughout the isochronous study) were analysed in triplicate, so 60 
measurements were performed in total. Measurements were carried out under intermediate 
precision conditions, whereby on each of the four measurement days, five samples were 
analysed in triplicate (15 analyses per day). Samples were analysed in a randomised order. 
The same LC-MS/MS method as for the homogeneity study was used, except that new 
calibration solutions were prepared and used.  
 
Data (Annex B) were first checked for single and double outliers by applying the Grubbs test 
at confidence levels of 95 % and 99 %, respectively. No outliers were detected. Data points 
were plotted against time and the regression lines were calculated (see Table 3 for a 
summary). The observed slopes were tested for significance using a t-test, with tα,df being the 
critical t-value (two-tailed) for a confidence level α = 0.05 (95 % confidence interval). The 
slope was considered as statistically significant when b/sb > t α,df .  
 
Whereas the slope was found to be indistinguishable from zero for storage temperatures of 4 
ºC and 18 ºC, a significant slope was found when the samples were stored at 60 ºC (95 % 
confidence level, t value 2.61, tcrit 2.07, no significant slope at 99 % confidence level). It was 
concluded that the uncertainty of the short-term stability (usts) can be assumed to be 
negligible if sample shipment is carried out at temperatures below 18 ºC. 
 
Table 3.  Short-term stability results for ERM-BB492 
Statistical parameters 4 ºC 18 ºC 60 ºC 
Slope (b) [%/week] -1.17 0.01 - 1.83 
|b|/sb 1.758 0.012 2.350 
Statistical significance 
(95% conf. interval) 1 no no yes 
usts [%/week] 0.693 0.607 1.314 
1
 t0.05;22= 2.074 
 
  14 
 
7.2 Long-term stability study 
A twelve months isochronous study [20] was performed to evaluate the stability of ERM-
BB492 and ERM-BB493 during storage, taking into account existing knowledge about 
stability of BCR-492. For ERM-BB493 (blank material), the concept of stability testing was to 
spike each sample with 100 µg/kg of OTC at the beginning of the sample preparation, and to 
verify potential alteration of the matrix during the storage time at different temperatures by 
analysing the samples. 
For ERM-BB492 and ERM-BB493, samples were picked from the produced batch using a 
random stratified sample picking scheme. Samples were stored at +4 °C and -20 °C, and at 
a reference temperature of -70 °C. Three bottles were stored at each temperature for 0, 4, 8, 
and 12 months, respectively. After the indicated periods, samples were transferred to -70 °C 
until analysis. Samples were dispatched on dry ice and kept at -70 ºC in the laboratory until 
analysis. In total, 21 samples (2 temperatures x 3 storage times x 3 units/time point = 18 
samples, and 3 samples stored at reference temperature throughout the isochronous study) 
were analysed in triplicate (for ERM-BB492) or in duplicate (for ERM-BB493). Moreover, two 
consecutive injections were made of each replicate, and the average was taken as the result 
for the replicate. In total, 126 measurements were performed for ERM-BB492, and 84 
measurements were performed for ERM-BB493. Samples were analysed under intermediate 
precision conditions (3 measurement days for ERM-BB492, 2 measurements days for ERM-
BB493). For this, one replicate of each sample was analysed on each analysis day.  
 
For both materials, the same LC-MS/MS method as for the short-term stability study was 
applied, except that a different type of reverse-phase LC column (Symmetry® C18, Waters, 
instead of Aqua™, Phenomenex) was used and the aqueous mobile phase was slightly 
adapted. 
 
For both ERM-BB492 and ERM-BB493, significantly different day means were obtained 
(verified by a t-test, data not shown). Consequently, values were normalised to the 
respective day means. 
 
Data (Annex C) were checked for single and double outliers by applying the Grubbs test at 
confidence levels of 95 % and 99 %, respectively. For ERM-BB492, one outlier was detected 
(95 % and 99 % confidence level); in-depth data inspection showed a considerably smaller 
peak area compared to other samples, but a possible extraction and/or pipetting problem 
during sample preparation could not be confirmed by the laboratory, therefore the data was 
retained. No outlier was detected in the series of ERM-BB493. 
 
Data points were plotted against time and the regression lines were calculated to check for 
significant trends (degradation, enrichment) due to storage conditions. The observed slopes 
were tested for significance using a t-test, as described in section 7.1. 
 
Finally, the uncertainty of stability ults [21] was calculated for a pre-defined shelf life of 2 years 
as: 
( ) xxx
RSD
u
i
stab
lts ⋅
−
=
∑
2
 
with RSDstab being the relative standard deviation of all 36 individual results of the relevant 
stability study, xi being the time point for each replicate, x being the average of all time points 
and x being the pre-defined shelf life. Results are summarized in Table 4. 
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Table 4. Long-term stability results for ERM-BB492 and ERM-BB493 
 ERM-BB492 ERM-BB493 
Statistical parameter -20 ºC 4 ºC -20 ºC 4 ºC 
Slope (b) [%/year] -1.11 3.69 -0.07 -0.23 
|b|/sb 0.56 2.69 0.04 0.11 
Statistical significance 
(95% conf. interval) 1 no yes no no 
ults [%/2 years] 3.907 5.056 3.979 3.893 
1 t0.05;34= 2.032 for ERM-BB492, t0.05;22= 2.074 for ERM-BB493 
 
For ERM-BB492, a statistically significant positive trend was obtained at 4 ºC (95 % 
confidence level, no trend at 99 % level). However, this trend can be regarded technically 
irrelevant, as (i) the content of OTC in the material cannot increase, (ii) the results for the 
blank material ERM-BB493 show the same variance in overall results and no degradation of 
the matrix, and (iii) because of a random agglomeration of data points around 1.03 
(normalised values) at the time point 12 months, which makes the trend statistically 
significant (Annex C, figure C2). 
 
For ERM-BB493, no significant slopes at the 95% level of confidence were detected, 
demonstrating stability of the material under these conditions. For both materials, -20 ºC was 
chosen as the storage temperature for the batch. 
  16 
8 Characterisation 
8.1 Calibrants used 
8.1.1 Oxytetracycline (OTC) 
A common calibrant (OTC hydrochloride, pure substance) was purchased from Sigma-
Aldrich (Bornem, BE), and distributed by IRMM. Prior to calibrant dispatch to the laboratories, 
the purity was assessed by a set of methods, which included liquid chromatography with 
diode array detection (LC-DAD), coulometric Karl Fischer titration (cKFT), differential 
scanning calorimetry (DSC), total ash content, and residual solvent determination using 
thermogravimetry coupled to Fourier-transformed infrared spectrometry (TG-FTIR). 
Additionally, both material identity and purity were assessed by quantitative nuclear magnetic 
resonance (qNMR) spectrometry. Finally, LC coupled to time-of-flight (TOF) mass 
spectrometry was applied to monitor the presence of compounds other than OTC (EOTC) in 
the material preparation.  
 
Differential scanning calorimetry (DSC) was not applicable due to decomposition of the 
compound during sample heating. 
 
LC-TOF analysis revealed 3 detectable impurities (peaks), which accounted for about 3.1 
area % of the total peak area including OTC. The largest impurity peak (2.3 area %) was 
identified as 2-acetyl-2-decarboxamidooxytetracycline (ADOTC) and the second largest peak 
(0.5 area %) as tetracycline (TC); this was accomplished by comparing the exact masses 
with those in the literature. This result corroborates findings concerning major impurities of 
manufactured OTC being ADOTC and TC [23]. The identity of the third peak (0.3 area %) 
could not be elucidated.  
 
Total ash determination according to the European Pharmacopeia 6.0 method yielded the 
result "below limit of detection of the method" (< 0.05 m/m %). 
 
HPLC-DAD purity (mean ± SD, n=3), expressed as a ratio of OTC peak area to sum of areas 
from all peaks in chromatogram was 98.7 ± 0.1 % and 99.1 ± 0.1 %, respectively. Results 
were obtained by two methods that differed by type of LC column (reversed-phase; styrene-
divenylbenzene copolymer R), mobile phase (phosphate pH 6.5; phosphate pH 7.5 
containing 2-methyl-2-propanol, tetrabutylammonium hydrogen sulphate, and EDTA), 
gradient, and detection wavelength (240 and 220 nm). 
 
cKFT measurements indicated a water content of 4.96 ± 0.37 g/100g (mean ± SD, n=5). 
 
Thermogravimetry coupled to Fourier-transform infrared spectrometry (TG-FTIR) analysis 
determined residual solvents, reported as sum of water and methanol, with 5.32 ± 0.13 
g/100g (mean ± SD, n=3).  
 
qNMR has been used in pharmaceutical sciences for several applications, including purity 
determination of pharmaceutical and chemical compounds [22]. Two laboratories performed 
six independent qNMR measurements each; both laboratories used 600 MHz instruments, 
but methods differed by the exact instrumental settings, the internal standard used for 
quantification, and the sample amount used per analysis. Table 5 lists the results obtained 
(g/g %). All qNMR results were taken into account to calculate the purity of the common 
calibrant. It amounts to 94.34 ± 0.61 g/g % (mean ± SD, n=12). This value could be nicely 
confirmed, taking into account the results obtained by the different purity methods, which 
yielded a total impurity of about 6 g/g % (sum of LC-DAD, and TG-TFIR which includes 
water).  
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Table 5. qNMR results (in g/g %) for the OTC 
calibrant used in the characterisation exercise  
Sample Laboratory A Laboratory B 
1 94.25 94.12 
2 94.24 95.18 
3 93.79 94.88 
4 94.03 94.77 
5 93.59 95.09 
6 93.32 94.87 
Average 93.87 94.82 
SD 0.37 0.37 
RSD% 0.40 0.39 
 
As a conservative estimation of the corresponding relative uncertainty of the common 
calibrant ucal, the half-width of a rectangular distribution between the highest and lowest value 
of all NMR results was taken: 
 32
resultlowest  -result highest 
⋅
=calu  
ucal amounts to 0.537 g/g %, and ucal [%] to 0.569. 
 
8.1.2 4-epi-oxytetracycline (EOTC) 
qNMR indicated a purity of 82.9 ± 2.2 g/g % (mean ± SD, n=6). This value was corroborated 
by the results obtained by other purity measurements (see details about methods above): 1.9 
± 0.1 area % organic impurities (HPLC-DAD), 17.87 ± 0.33 g water/100g (cKFT), 16.59 ± 
0.39 g/g % water (TG-FTIR), total ash <LOD of method, which combined indicates about 81 
% purity of the commercial EOTC. 
 
8.2 Design of the study 
Exclusively LC-UV and LC-MS/MS methods were applied for the characterisation of the 
reference material, as these are by far the predominantly used techniques nowadays.  
 
Twelve laboratories were selected for analysing ERM-BB492 based on the following criteria: 
validated methods were an indispensable requirement for participation; accreditation of the 
laboratory for this method was considered an asset. Ten laboratories operated methods 
executed under the scope of their accreditation, one laboratory was not yet accredited for 
these measurements, and one laboratory operated a method in compliance with GLP 
according to Directive 2004/9/EC [24]. The laboratories had to prove their measurement 
capabilities and had to demonstrate previous experience in OTC analysis in milk (e.g. results 
from recent proficiency testing rounds).  
 
For ERM-BB493 (blank material), the seven laboratories operating methods with an LOD < 
15 µg/kg for the sum of OTC and EOTC (method validation data commuciated by the 
laboratories, see table 11) were participating in the intercomparison. 
For the characterisation study, each laboratory was provided with the following samples: 
• 3 vials of ERM-BB492 (and 3 vials of ERM-BB493, when applicable) 
• 1 bottle (ca. 60 g) of blank milk powder 
• 1 vial each of pure OTC and EOTC neat substance (ca. 250 mg and 100 mg, 
respectively) 
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Laboratories were required to apply their validated LC-UV or LC-MS/MS methods and were 
required to use the provided neat substance for calibration purposes. Preparation of 
calibration curves was done according to the laboratories' method working instructions (neat 
standard solution calibration or matrix-matched calibration). Three independent sub-samples 
of each vial had to be prepared and analysed, amounting to nine analysis of ERM-BB492. 
Measurements had to be performed on three different days (three analyses/day), with 
independent calibrations on each day.  
 
Reconstitution of the samples was prescribed by IRMM and was performed as follows: to 
1.00 g powder, 8.15 g of distilled water was added. Higher or lower amounts of milk powder 
could be used if required by the laboratory's working instruction, whereby the 1:8.15 m/m 
ratio of powder to water had to be maintained. The sample was homogenised by adding a 
magnetic stirring bar to each powder/water mixture, and stirred for 10 - 15 min at room 
temperature. 
 
The blank milk powder provided was used for the preparation of quality control (QC) samples 
(blank matrix sample, sample spiked at low µg/kg level), and for the preparation of matrix-
matched calibration when applicable. - The same study set-up held for ERM-BB493, except 
that two independent sub-samples of each vial had to be prepared and analysed, which 
amounted to six analyses (two per day) in total. 
 
8.3 Results and technical evaluation 
Only the methods applied in laboratories 2, 6, and 7 chromatographically separated OTC 
from EOTC, in all other methods co-elution of the two epimers was obtained. The results in 
laboratories 2, 6 and 7 showed that ERM-BB492 did not contain detectable amounts of 
EOTC. This supports previously published data (EOTC below LOD of methods in milk, [13]), 
and indicates that an in vivo-formation of EOTC from OTC is not taking place in the material. 
Moreover, apparently OTC does not epimerize to EOTC during sample preparation in 
detectable amounts with the procedures applied. 
 
The individual methods employed by the laboratories are summarised in Tables 6 - 9 
(sample preparation and calibration; overview LC-MS/MS and LC-UV methods; transitions 
and ions used for quantification). Only laboratories 2, 6, and 7 operated methods which 
separate OTC from EOTC; consequently, calibration was performed using both neat OTC 
and neat EOTC. All other methods did not separate OTC and EOTC, and calibration was 
performed with neat OTC exclusively.  
 
It can be seen that the laboratory methods varied substantially in terms of employed 
extraction solution and clean-up procedure. Also, sample intakes varied more than one order 
of magnitude. All laboratories applied matrix-matched calibration. Only half of the 
laboratories used an internal standard, the others reported that according to their experience 
the use of an internal standard does not enhance the quality of the obtained data. 
 
LC-MS/MS methods differed in the type of reversed-phase column used (dimension, particle 
size), eluents, and specific compound-dependent MS parameters (dwell time, collision 
energy) as well as in source/gas-related MS-settings (temperature at ionisation point, ion 
spray voltage, curtain gas, etc.). All laboratories operated their ionisation source in the 
positive ESI mode, and the mass spectrometer was used as a triple quadruple spectrometer 
in the multiple reaction monitoring (MRM) mode. The majority of labs used transition 
461>426 for quantification, and laboratories 2 and 4 used two transitions (Table 9).  
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Table 6. Methods in the characterisation study – sample preparation and calibration 
Lab 
code 
Sample 
intake [g]1 Extraction solution Clean-up Calibration
2
 Internal standard 
1 5 Succinate buffer MCAC,  
SPE (lipophilic-hydrophilic 
copolymer) 
Matrix-matched 
(powder)3 
-  
2 5 Trichloroacetic 
acid 
 
SPE (lipophilic-hydrophilic 
copolymer) 
Matrix-matched 
(powder)4 
4-epidemeclocycline 
HCl, EPE0440000, 
lot 1, 
LGC Promochem 
(origin EDQM) 
3 3 Water, EDTA,  
acetonitrile 
- Matrix-matched 
(powder)3 
- 
4 6 Carrez I and II5, 
McIlvaine buffer6 
SPE (reverse-phase) Matrix-matched 
(powder)3 
Demeclocycline HCl, 
D6140, 
lot 066K1213, 
Sigma Aldrich 
5 5 Trichloroacetic 
acid, Mc Ilvaine 
buffer6 
SPE (lipophilic-hydrophilic 
copolymer) 
Matrix-matched 
(powder)3 
Demeclocycline HCl, 
46161, 
lot 6129X, 
Riedel-de-Haën 
6 5 Succinate buffer, 
trichloroacetic acid 
SPE (lipophilic-hydrophilic 
copolymer) 
Matrix-matched 
(powder)4 
Demeclocycline HCl, 
D6140, 
lot 1438182, 
Sigma Aldrich 
7 1 Trichloroacetic 
acid, 
Mc Ilvaine buffer6 
SPE (lipophilic-hydrophilic 
copolymer) 
Matrix-matched 
(powder)4 
- 
8 2 Triochloroacetic 
acid 
- Matrix-matched 
(powder)3 
Demeclocycline HCl, 
C12128000, 
lot 70920, 
Dr. Ehrenstorfer 
9 2 Water, EDTA, 
McIlvaine buffer6, 
Trichloroacetic 
acid 
SPE (reverse-phase) Matrix-matched 
(powder)3 
Demeclocycline . 
HCl, D6140, 
lot 1438182, 
Sigma Aldrich 
10 5 EDTA, 
hydrochloric acid 
SPE (cyclohexyl phase) Matrix-matched 
(powder)3 
- 
11 0.5 EDTA, McIlvaine 
buffer6 
Ultrafiltration (30 kD) Matrix-matched 
(powder)3 
- 
12 3.5 Succinate buffer, 
EDTA 
Delipidation with heptane; 
SPE (reverse-phase) 
Matrix-matched 
(powder)3 
- 
1
 reconstituted material 
2
 powder: blank provided by IRMM 
3
 laboratory used exclusively OTC for calibration 
4
 laboratory used OTC and 4-epi-OTC for calibration 
5
 Carrez I, zinc acetate solution; Carrez II, potassium hexacyanoferrate solution 
6
 citric acid/disodium hydrogen phosphate buffer 
 
 
LC-UV methods differed in the type of reversed-phase column, eluents, and detection 
wavelength. 
 
The individual results as obtained are listed in Annex D. 
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Table 7. LC-MS/MS methods in the characterisation study – separation and quantification 
Lab 
code 
LC column Solvent system HPLC system Mass spectrometer1,2 
2 AlltimaTM C18, 150 x 2.1 mm,  
3 µm (Alltech) 
Formic acid/ 
(methanol/acetonitrile) 
Alliance 2695 
(Waters) 
Quattro LCZ 
(Micromass) 
3 GENESIS® C18, 100 x 2.1 mm,  
4 µm (Grace) 
(Formic acid/oxalic 
acid)/acetonitrile 
1200 
(Agilent) 
6410 
(Agilent) 
4 Gemini® C18, 150 x 4.6 mm,  
3 µm (Phenomenex) 
Formic acid/ 
acetonitrile 
Alliance 2695 
(Waters) 
Quattro Micro API 
(Waters) 
6 AcquityTM UPLC BEH-C18, 
50 x 2.1 mm, 1.7 µm (Waters) 
Formic acid/ 
acetonitrile 
AcquityTM UPLC 
(Waters) 
Quattro Premier XE 
(Micromass) 
7 Symmetry® C18, 150 x 3.9 mm, 
5 µm (Waters) 
Formic acid/ 
acetonitrile 
1100 
(Agilent) 
API 3000 
(Applied Biosystems) 
8 Gemini®-NX C18, 150 x 2 mm, 
3 µm (Phenomenex) 
Formic acid/ 
methanol 
Alliance 2695 
(Waters) 
Quattro Premier 
(Micromass) 
9 Symmetry® C18, 100 x 2.1 mm, 
3.5 µm (Waters) 
Pentafluoropropionic 
acid/acetonitrile 
1100 
(Agilent) 
API 4000 
(Applied Biosystems) 
10 Kinetex™ C18, 50 x 2 mm, 
2.6 µm (Phenomenex) 
Formic acid/ 
acetonitrile 
1200 
(Agilent) 
API 4000 
(Applied Biosystems) 
12 Symmetry® C18, 150 x 2.1 mm, 
5 µm (Waters) 
Trifluoroacetic 
acid/acetonitrile1 
Alliance 2695 
(Waters) 
Quattro Ultima Pt 
(Waters) 
1
 isocratic elution 
 
Table 8. LC-UV methods in the characterisation study – separation and quantification 
Lab 
code 
LC column Solvent system HPLC system Detector, 
detection 
wavelength 
1 Zorbax SB C18, 150 x 4.6 mm,  
3.5 µm (Agilent) 
Oxalic acid/ 
acetonitrile1 
Module: 305 pump, 231 XL 
autosampler, 402 dilutor 
(Gilson) 
UV-975 UV/VIS 
(Jasco),  
350 nm 
5 Superspher® 60 RP-8 endcapped, 
250 x 4 mm, 5 µm (Merck)  
Citric acid/ 
acetonitrile 
Module: LC-10 AT VP 
pumps, SILL 10 AT VP 
injector, CTO 10 AT VP 
column oven, FCV 11 ALL 
mixer, SCL 10 A controller 
(Shimadzu) 
SPD-M10A 
(Shimadzu),  
355 nm 
11 Purospher RP C18 endcapped, 
125 x 4 mm, 5 µm (Merck) 
Oxalic acid/ 
acetonitrile1 
Module: P 4000 pump, 
AS300 autosampler, 
Chromquest data station 
(Thermo) 
UV 6000 LP 
(Thermo),  
354 nm 
1
 isocratic elution 
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Table 9. LC-MS/MS methods in the characterization study - MRM transitions1 used for 
quantification.  
Lab. 
code 
OTC 
2 461>444 
461>426 
3 461>426 
4 461>426 
461>443 
6 461>426 
7 461>426 
8 461>426 
9 461>426 
10 461>426 
12 461>443 
1
 Values represent the parent (molecular ion) and the daughter ion, respectively 
 
 
ERM-BB492 
Laboratories 1 and 10 (no internal standard used) corrected their results for recovery 
obtained in the QC samples within the analytical series (blank milk powder provided by 
IRMM, spiked with common calibrant), which was about 82 and 60 %, respectively. 
Laboratories 3, 7 and 11 (no internal standard used) did not correct their results, as the QC 
samples indicated recoveries close to 100 %. All other laboratories used internal standards, 
and did not correct their results for recovery. 
 
All results were subjected to technical evaluation. The obtained data sets from laboratories 2 
and 8 were rejected as the data did not meet the specified quality requirements of IRMM 
(cases of non-linear calibration lines, reported possible error in the preparation of the 
calibrant stock solution, some recovery values of QC samples either substantially changing 
from day to day or largely exceeding 100 %). For laboratory 12, the data of the first day had 
to be rejected, as the laboratory reported problems with obtaining a linear calibration line due 
to saturation problems with the ion source of the mass spectrometer (problem solved on 
days 2 and 3, linear calibration lines). 
 
In total, 87 results from 10 laboratories were accepted after technical scrutiny and subjected 
to statistical data assessment. The accepted sets of results were submitted to the following 
statistical tests: 
− Scheffe's multiple t-test to check if the means of two labs are significantly different 
− Dixon's test to detect outlying lab means 
− Grubb's test to detect single and double outliers 
− Cochran test to check for outlying lab variances 
− Bartlett test to check for homogeneity of lab variances 
− Skewness and Kurtosis test to assess the normality of the lab means distribution.  
 
Datasets were first subjected to the Cochran test to identify outlying laboratory variances. No 
outlying variances were detected. The results of the statistical tests of the finally considered 
data for ERM-BB492 are summarized in Table 10. It shall be noted that this mean value had 
to be multiplied with 0.9434, the relative purity of the common calibrant. Also, the data in 
Annex D refers to the results as obtained, where the laboratories when reporting their data 
were requested to assume 100% purity for the common calibrant. The correction was only 
made to the mean of means and its absolute combined uncertainty and expanded 
uncertainty. 
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uchar was estimated as the standard error of the mean of laboratory means:  
 
n
s
uchar =  
with s being the standard deviation of the mean of means, and n the number of accepted set 
of data 
 
 
Table 10. Summary of statistical evaluation for ERM-BB492 
Parameter  
Number of data sets 10 
Number of replicate measurements1 87 
Mean of means [µg/kg] 107.495 
Mean of means [µg/kg] after correction with common 
calibrant purity (0.9434) 101.411 
Relative standard deviation of mean of means [%] 5.165 
Relative standard error of mean of means [%], uchar 1.633 
All data sets compatible two by two? 
(Scheffe's test) No 
Outlying means? (Dixon test)  No 
Outlying means? (Grubbs test)  No 
Outlying lab variances? (Cochran test) No 
Lab variances homogeneous? (Bartlett test) No 
Distribution of means normal? (Skewness & kurtosis, 
normal probability plot) Yes 
α = 0.05 unless stated otherwise 
 
1
 only 6 measurements for laboratory 12 (mass spectrometer ion source problems on day 1) 
 
ERM-BB493 
Only laboratories with a LOD < 15 µg/kg were participating in analysing ERM-BB493; these 
were laboratories 1, 4, 6, 7, 8, 9, and 12. The results for OTC were reported as "not 
detected" by all laboratories. The result of laboratory 8 was not taken into account, as a 
consequence of the insufficient data quality of the ERM-BB492 measurements (see above).  
 
Table 11 lists the LOD values of the methods; the values were established in the laboratories 
during validation of the methods, and were calculated as indicated in the table. For 
laboratories 6 and 7, values represent the LOD of OTC, whereas for all other labs, values are 
the LOD of the sum of OTC and EOTC. 
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Table 11. LOD values for OTC (sum of OTC and EOTC) 
in the methods of the characterization study 
Lab. LOD [µg/kg] 
Basis of value  
 
1 1.9 S/N = 3 (matrix blank) 
4 5 Spiked sample 
6 0.12 Extrapolation to S/N = 3 from sample spiked at 10 µg/kg 
7 10 S/N = 3 (matrix blank) 
9 5 S/N = 3 (matrix blank) 
12 1.4 S/N = 3 (matrix blank) 
 
In addition to the information provided, chromatograms of blank milk and lowest level 
calibration curve samples (data of characterization exercise) were inspected in detail during 
results evaluation at IRMM to verify that the communicated LODs are meaningful.  
 
Laboratory 6 reported a LOD which is considerably lower than that of the other five 
laboratories. In-depth data evaluation revealed that this LOD (estimated by extrapolation 
from a spiked sample at an approximately 100-fold higher concentration) is questionable; 
therefore this value was not taken into account for further calculations. The validity of the 
other five values could be confirmed. Therefore, the lowest of the remaining five values (1.4 
µg/kg) was taken, and multiplied by 3.3 (conservative estimation, [25]) to obtain the 
corresponding LOQ, yielding 4.6 µg/kg. 
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9 Certified values and uncertainties 
The certified value for ERM-BB492 is calculated as the mean of means of the accepted data 
sets. The standard error of the mean of means was used as an estimation of the uncertainty 
contribution of the characterisation exercise. The standard error is calculated as the standard 
deviation divided by the square root of the number of accepted data sets. 
The combined uncertainty of the certified value includes contributions from the between- 
bottle heterogeneity, long-term storage, the characterisation study, and from the common 
calibrant (purity). The relative combined uncertainty is calculated as the square root of the 
sum of squares of the relative uncertainties of the individual contributions, according to: 
2222
calcharltsbbCRM uuuuu +++=  
Table 12 summarizes the individual uncertainty contributions and the resulting expanded 
uncertainty, and indicates the certified value and its uncertainty after rounding. 
 
Table 12. Certified value and uncertainty for ERM-BB492 
Parameter  
ubb [%] 2.999 
ults [%]1) 3.907 
uchar [%] 1.633 
ucal [%] 0.569 
uCRM, rel [%] 5.220 
UCRM,rel (k=2) [%] 10.440 
Certified value [µg/kg] 101 
UCRM (k=2) [µg/kg] 11 
1)
 shelf life 24 months 
 
For ERM-BB493, the certified value (mass fraction) for the sum of OTC and EOTC has been 
assigned as "< 5 µg/kg with a 95% level of confidence". This value corresponds to the LOQ 
of the most sensitive method in the characterisation study.  
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10 Metrological traceability 
The measurement results for assigning a mass fraction value for the sum of OTC and EOTC 
to the material were obtained by employing methods with different sample preparation 
procedures (from extraction with different organic solvent and/or aqueous buffers, without 
any clean-up, up to extensive sample preparation metal-chelate affinity chromatography and 
solid-phase extraction). Therefore, independence of the results from the sample preparation 
part can be concluded.  
  
LC-UV and LC-MS/MS methodologies were used for analyte separation and quantification, 
thereby defining the measurand. For the LC-MS/MS methods, the liquid chromatography 
parts of the methods mainly differed in type of eluents used, the type of reversed phase 
columns applied (particle size, column dimension), and LC system differences (HPLC 
systems, flow rate, column temperature, injected sample amount). The mass spectrometry 
parts exclusively used positive electro-spray ionisation and utilised the instruments in the 
triple quadrupole configuration by applying tandem mass spectrometry in the multiple 
reaction monitoring mode. Most of the methods used the same transition (parent ion, 
daughter ion) for quantification. Nevertheless, MS methods differed in some compound-
dependent parameters (dwell times, collision energies) as well as in source/gas-related MS-
settings (temperature at ionisation point, ion spray voltage, curtain gas, etc.). The applied 
LC-UV methods differed in the type of column, mobile phases, injection amount, and 
detection wavelength. Therefore, independence of the results can be concluded as long as 
LC-UV and LC-MS/MS methodologies are applied. 
 
The common calibrant (crystalline substance) was provided by IRMM. The purity was 
assessed by qNMR (two data sets) and verified using a set of purity assessment methods 
including LC-DAD (two methods), cKFT, total ash determination according to European 
Pharmacopoeia 6.0, TG-FTIR, and LC-TOF. The certified value is traceable to the 
International System of Units (SI) via the common calibrant used. 
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11 Instructions for use 
11.1 Safety precautions 
The usual laboratory safety precautions apply. 
11.2 Reconstitution of the material 
• Allow the bottle to warm up to ambient temperature; shake vigorously for at least 30 s 
before opening. 
• Weigh accurately an aliquot of 1.00 ± 0.01 g. The weighing should be performed 
immediately after opening of the vial to minimise water uptake by the lyophilised powder.  
• Add an accurately weighed amount of 8.15 ± 0.01 g of distilled water to the powder. 
• The sample has to be homogenised by adding a magnetic stirring bar to each 
powder/water mixture, and stirring for 10 - 15 min at room temperature. 
• In case the working instruction of the laboratory's method foresees a higher/lower sample 
intake than 9.15 g of reconstituted material, the 1:8.15 (m/m) ratio of powder to distilled 
water has to be maintained. It shall be noted that most methods have smaller sample 
intakes per analysis, and that the sample intake usually is an aliquot of the reconstituted 
milk. 
11.3 Intended use 
This material is intended to be used for method performance control and validation purposes 
(trueness determination). For assessing the method performance, the measured values of 
the CRMs are compared with the certified values following a procedure described in ERM 
Application Note 1 [26]. The procedure is described here in brief: 
• Calculate the absolute difference between mean measured value and the certified 
value (∆m). 
• Combine measurement uncertainty (umeas) with the uncertainty of the certified value 
(uCRM): 22 CRMmeas uuu +=∆  
• Calculate the expanded uncertainty (U∆) from the combined uncertainty (u∆) using a 
coverage factor of two (k = 2), corresponding to a confidence interval of 
approximately 95 % 
• If ∆m ≤  U∆ then there is no significant difference between the measurement result and 
the certified value, at a confidence level of about 95 %. 
11.4 Storage conditions 
The materials should be stored at a temperature of -20 ± 5 °C. However, the European 
Commission cannot be held responsible for changes that happen during storage of the 
material at the customer’s premises, especially of open samples. 
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Annex A. Homogeneity data 
Table A1. Results of the homogeneity study. Values are the sum of OTC and EOTC in µg/kg 
Bottle 
number 1
st
 replicate 2nd replicate 3rd replicate 
39 120.7 125.4 137.2 
149 124.2 127.7 129.7 
205 121.5 126.2 137.2 
325 124.0 121.8 133.8 
361 125.3 118.7 128.8 
444 119.9 112.8 125.5 
553 126.2 123.8 134.4 
623 123.4 123.0 141.6 
766 121.2 126.9 142.5 
841 115.7 108.8 119.9 
918 121.5 119.5 123.5 
981 116.8 119.1 123.5 
1079 122.3 118.3 136.3 
1128 120.1 116.7 128.0 
1235 129.7 117.5 129.1 
 
 
 
 
 
 
 
Figure A1. Homogeneity of OTC in ERM-BB492. The x axis depicts the sample numbers (filling 
sequence). The indicated points are mean values of triplicate measurements. 
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 Annex B. Short-term stability data 
Table B1. Results of the short-term stability study. Values are the sum of OTC and EOTC in 
µg/kg  
 
Time 
(weeks) 4 ºC 18 ºC 60 ºC 
0 119.5 119.5 119.5 
0 119.3 119.3 119.3 
0 112.4 112.4 112.4 
0 111.2 111.2 111.2 
0 124.1 124.1 124.1 
0 124.6 124.6 124.6 
1 111.9 114.8 122.0 
1 120.5 117.3 119.1 
1 113.0 113.6 109.7 
1 130.4 115.3 128.3 
1 125.4 115.6 128.7 
1 129.4 123.5 119.4 
2 118.5 120.0 118.8 
2 113.5 115.2 122.5 
2 118.3 124.4 126.8 
2 116.8 110.1 117.5 
2 117.8 117.9 116.0 
2 118.1 109.5 123.9 
4 110.2 107.7 107.3 
4 116.5 114.1 110.8 
4 106.0 118.7 103.8 
4 116.6 124.5 115.8 
4 116.9 121.2 103.5 
4 120.2 123.0 123.3 
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Figure B1. Short-term stability for OTC at 4 ºC.  
 
 
Figure B2. Short-term stability for OTC at 18 ºC.  
 
 
Figure B3. Short-term stability for OTC at 60 ºC.  
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Annex C. Long-term stability data 
Table C1. Results of the long-term stability study. Values are the sum of OTC and EOTC in 
µg/kg  
ERM-BB492 ERM-BB493 
Time 
(months) 4 ºC -20 ºC 
Time 
(months) 4 ºC -20 ºC 
0 111.90 111.90 0 100.50 100.50 
0 99.20 99.20 0 110.80 110.80 
0 109.50 109.50 0 98.45 98.45 
0 104.35 104.35 0 97.90 97.90 
0 95.80 95.80 0 95.90 95.90 
0 100.10 100.10 0 95.25 95.25 
0 101.25 101.25 4 103.00 99.35 
0 96.10 96.10 4 101.80 100.05 
0 101.20 101.20 4 96.05 97.55 
4 102.00 103.05 4 107.85 106.60 
4 99.45 96.65 4 98.25 96.95 
4 102.60 106.50 4 100.05 98.10 
4 113.10 113.00 8 97.65 99.00 
4 99.20 102.00 8 99.70 100.40 
4 103.40 104.00 8 95.75 101.05 
4 106.70 111.55 8 106.40 108.90 
4 101.15 99.45 8 98.25 92.60 
4 100.70 105.05 8 97.90 103.95 
8 112.70 106.90 12 99.45 95.90 
8 102.80 102.25 12 102.50 104.60 
8 108.10 105.90 12 101.20 94.40 
8 113.55 90.55 12 103.40 103.40 
8 101.40 95.55 12 95.00 97.55 
8 104.25 103.15 12 99.50 100.40 
8 106.00 115.35    
8 96.90 96.65    
8 106.20 99.80    
12 112.10 107.25    
12 102.55 95.50    
12 106.75 98.70    
12 102.90 108.00    
12 102.00 102.85    
12 107.85 95.95    
12 110.35 109.90    
12 97.75 97.50    
12 107.60 100.65    
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Figure C1. Long-term stability for OTC in ERM-BB492 at -20 ºC.  
 
 
Figure C2. Long-term stability for OTC in ERM-BB492 at 4 ºC.  
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Figure C3. Long-term stability for OTC in ERM-BB493 at -20 ºC.  
 
 
Figure C4. Long-term stability for OTC in ERM-BB493 at 4 ºC.  
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Figure C5. Long-term stability for OTC in ERM-BB492 at -20 ºC with associated ults for storage period 
of 24 months 
 
Figure C6. Long-term stability for OTC in ERM-BB493 at -20 ºC with associated ults for storage period 
of 24 months 
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Annex D. Characterisation data 
Table D1. Results of the characterisation measurements for oxytetracycline. Values (sum of 
OTC and EOTC in µg/kg) as obtained, not corrected for common calibrant purity. The graph 
shows laboratory mean values and the mean of means. Error bars are standard deviations. 
Results with a low standard deviation may well have a large measurement uncertainty. 
Lab code Day1/1 Day1/2 Day1/3 Day2/1 Day 2/2 Day 2/3 Day 3/1 Day 3/2 Day3/3 
1 118.02 112.67 118.09 118.25 122.15 119.49 108.68 111.90 111.87 
21 129.91 125.25 133.29 145.04 130.58 129.16 114.18 133.11 112.47 
3 113.71 114.22 111.68 108.61 104.84 104.13 101.48 101.09 96.87 
4 102.40 101.60 91.76 97.78 107.81 109.42 90.48 95.53 87.55 
5 132.87 118.60 123.98 98.22 99.70 98.78 108.13 109.89 109.15 
6 119.70 109.40 109.00 98.50 103.90 112.00 100.20 111.20 106.90 
7 116.36 110.37 111.52 115.18 106.21 111.28 107.13 109.94 117.43 
81 132.80 143.37 153.48 119.00 149.79 157.86 153.86 169.41 167.98 
9 113.05 115.83 101.93 106.56 92.66 101.00 112.12 96.37 102.85 
10 110.28 95.74 92.51 94.50 122.16 112.03 126.53 118.82 125.85 
11 103.71 99.20 102.29 107.14 116.84 104.02 116.26 117.69 116.93 
12 129.45 139.33 143.82 111.02 106.43 104.80 87.66 102.13 82.68 
1data sets rejected for technical reason (see page 21) 
2
 Laboratory 12, day 1, data (in italic): not taken into account for calculating laboratory mean due to technical 
reason (see page 21) 
 
 
Figure D1. Laboratory means, mean of means and their standard deviations for sum of OTC and 
EOTC as obtained (not corrected for common calibrant purity) 
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Abstract 
 
This report describes the preparation of two milk powder matrix reference materials (ERM-BB492 and ERM-BB493) 
and the certification of their content (mass fraction) of oxytetracycline. 
 
The preparation and processing of the material, homogeneity and stability studies, and the characterisation are 
described hereafter and the results are discussed. Uncertainties were estimated in compliance with ISO Guide 98-3, 
Guide to the Expression of Uncertainty in Measurement (GUM) [1]. 
 
For ERM-BB492, the uncertainty contains contributions from possible heterogeneity, instability, characterisation, and 
purity of the common calibrant. The certified value is listed below: 
 
Mass fraction in the reconstituted 
material 
Certified value 1) 
[µg/kg] 
Uncertainty 2) 
[µg/kg] 
Number of accepted 
sets of results 
Sum of oxytetracycline and 4-epi-
oxytetracycline  101 11 10 
1) The value represents the mass fraction based on the unweighted mean of means of accepted results. 
2) Expanded uncertainty (k = 2) of the value defined in 1). 
 
The certified value and its uncertainty is based on a minimum sample intake of 1.00 g reconstituted material. 
 
 
For ERM-BB493, the following certified value has been assigned: 
 
Mass fraction in the reconstituted 
material 
Certified value 1) 
[µg/kg] 
Sum of oxytetracycline and 4-epi-
oxytetracycline  < 5 
1) This value corresponds to the limit of quantification (LOQ) of the most sensitive method in the characterisation study. The 
certified value is below 5 µg/kg with a 95% level of confidence. 
 
The indicative value is based on a minimum sample intake of 3.50 g reconstituted material. 
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